Abstract
The global pharmaceutical pricing and reimbursement environment is notoriously
complex and continuously changing. Pharma companies must implement strategic
pricing assessments across global markets and product lifecycle phases in
order to develop effective pricing policies. By incorporating such assessments
into portfolio evaluations and lifecycle planning, companies can enhance their
understanding of potential price profiles for individual drugs and optimise
future returns. ' Pharmaceutical Pricing and Reimbursement' is a new report
published by Business Insights that examines the tactical importance of price
optimization throughout the product lifecycle. The key issues affecting
pricing and reimbursement disciplines are identified and the market
environments of individual countries are assessed. This report will also
detail the global and lifecycle pricing strategies of new and established
drugs, including actionable recommendations and detailed case studies, and
provide forecasts for future pricing scenarios in major markets.
View Cart
